Patients with Diabetes

High-risk Group for Diabetes

General Public

In managing the care continuum for patients with diabetes, the Kaohsiung Municipal United Hospital customizes therapeutic goals based on clinical severity. By leveraging AI-driven technologies to design tailored health education and clinical interventions, we ensure a safe, optimal, and empowered experience for patients throughout their 'Happy Glucose Control' journey.

Expansion of a multidisciplinary network of diabetes care physicians.

Implementation of one-stop integrated diabetes care services to minimize patient travel and transit time.

Establishment of the "Health Butler"—an AI-driven intelligent care platform enabling seamless, continuous health management.

Launch of the "Honey Club" (蜜糖Club), an innovative patient support group and community engagement initiative.

Development of innovative patient education materials and multimedia resources.

Provision of specialized outpatient counseling for diabetes education and self-management.

The multidisciplinary diabetes care team comprises 37 professionals, including 23 physicians, 4 certified diabetes educators (CDEs), 6 dietitians, 1 pharmacist, and 3 nursing administrative executives.

From 2021 to 2023, continuing medical education (CME) recorded 655 staff attendances, while specialized diabetes care training generated 23 educational sessions.

Total attendance at diabetes patient support group activities reached 204 participants (86 in 2021, 48 in 2022, and 70 in 2023).

The "Health Butler" platform successfully enrolled 1,470 cases, maintaining an active monthly user base of approximately 705 individuals.

Outpatient volume for specialized diabetes education clinics demonstrated steady growth, with 7,830 visits in 2021, 8,321 in 2022, and 8,853 in 2023.

Between 2021 and 2023, team members successfully published and presented 8 peer-reviewed research poster abstracts.

Diabetes care coverage rates from 2021 to 2023 were 83.38%, 88.05%, and 91.64%, respectively, consistently outperforming national benchmarks.

UACR Screening Rate: 78.80%, 84.45%, and 88.72%, all exceeding the national averages.

Diabetic Retinopathy Screening Rate: 75.79% in 2021, 76.53% in 2022, and 80.15% in 2023, continuously surpassing national benchmarks.

HbA1c control target compliance (HbA1c < 7%): 50.03%, 52.56%, and 57.57%.

Blood pressure control target compliance (BP < 130/80 mmHg): 61.63%, 64.37%, and 66.56%.

Lipid control target compliance (LDL-C < 100 mg/dL): 45.07%, 52.35%, and 54.16%.

Comprehensive ABC target achievement rates (combined control of HbA1c, Blood Pressure, and LDL-C): 25.79%, 26.89%, and 32.44%.

Poor glycemic control rate (HbA1c > 8.5%, negative indicator) demonstrated a steady annual decline: 14.14%, 10.38%, and 9.35%.

Smoking cessation success rates: 29.17% in 2021, 18.94% in 2022, and 75.36% in 2023.

Return visit rates for specialized diabetes health education: 80.15%, 82.43%, and 84.86%.

Ranked 1st nationwide among regional hospitals for diabetes care coverage rate in 2022.

Ranked 1st nationwide among regional hospitals for fundus examination and retinal photography screening rate in 2022.

Ranked 3rd nationwide among regional hospitals for microalbuminuria screening rate in 2022.

All instruments and equipment undergo routine preventative maintenance by designated personnel on a monthly basis, while biomedical engineering staff perform calibration and technical servicing for medical electronic equipment bi-monthly.

Quality control (QC) monitoring for glucometers is executed on a strict daily schedule.

The Department of Laboratory Medicine is equipped with advanced diagnostic instrumentation for hematology, biochemistry, and urinalysis. All systems undergo scheduled preventative maintenance by original equipment manufacturers (OEM) and hold accreditations from the Taiwan Society of Laboratory Medicine or equivalent international bodies.

Satisfaction rates for continuing education and clinical teaching: 97.6% in 2021, 98.5% in 2022, and 98.9% in 2023.

The 2023 Patient Education Materials Satisfaction Survey ($n = 782$ valid responses) demonstrated high approval across all dimensions: layout (97.60%), font size (96.00%), clarity and readability (98.40%), alignment with patient needs (99.01%), and overall satisfaction (97.30%).

Satisfaction rates for individualized diabetes education and counseling: 95.60% in 2021, 99.82% in 2022, and 97.86% in 2023.

Satisfaction rates for diabetes patient support group activities ("Honey Club"): 88.86% in 2021, 93.62% in 2022, and 94.97% in 2023.

Satisfaction rates for chronic disease wellness and health education programs: 91.40% in 2021, 88.70% in 2022, and 94.45% in 2023.

Recognized with the International Gold Forum Award for Smoke-Free Healthcare Services in 2023.

Our comprehensive diabetes care outcomes outperform Japanese benchmarks; specifically, both our UACR screening rate and diabetic retinopathy screening rate consistently exceed national indicators in Japan.

On average, each patient reduced their annual outpatient visits by more than 4 times, yielding a corresponding medical expense savings of NT$2,360 per capita per year.

The hospital's integrated care model successfully generated an annual aggregate savings of NT$339,840 across 144 integrated patient visits.

The streamline workflow effectively minimized transit and waiting times, reducing clinic journey times by 150 minutes for newly referred cases and 90 minutes for follow-up visits.

Awarded the Outstanding Tobacco Cessation Service Institution Award by the Ministry of Health and Welfare (MOHW) under the National Tobacco Cessation Subsidy Program in 2021.

Recipient of the First-Class Excellence Award for Quality Improvements in Diabetes Care from the Ministry of Health and Welfare (MOHW) in 2022, specifically recognizing achievements in New Case Volume, New Case Enrollment Rate, and Cross-Specialty Case Referrals.

Honored with the Outstanding Diabetes Care Excellence Award by the Kaohsiung City Department of Health under the Quality Improvements in Diabetes Care Incentive Program in 2022.

Awarded the Outstanding Tobacco Cessation Service Award for Regional Hospitals by the Kaohsiung City Department of Health in 2022.

Distinguished with the Quality Benchmark Award by the Kaohsiung City Department of Health under the Kaohsiung Diabetes Care Quality Enhancement Incentive Program in 2023.